Capricor Therapeutics reported $18.73M in Equity Capital and Reserves for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Bluebird Bio BLUE:US $ 180.12M 83.14M
Capricor Therapeutics CAPR:US $ 18.73M 5.91M
Cytokinetics CYTK:US $ 111.41M 4.85M
Cytori Therapeutics CYTX:US $ 9.68M 4.96M
Geron GERN:US $ 142.05M 44.56M
Newlink Genetics NLNK:US $ 74.55M 7.27M
Prothena PRTA:US $ 407.3M 31.59M
Ptc Therapeutics PTCT:US $ -182.22M 91.64M
Sarepta Therapeutics SRPT:US $ 726.46M 130.43M
Vascular Biogenics VBLT:US 34.37M 8.42M
Vital Therapies VTL:US $ 127.85M 10.11M